Request for Covid-19 Impact Assessment of this Report
Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells and slows their spread in the body
The global Erlotinib Hydrochloride market will reach xxx Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Roche
Cipla
Mylan
Teva
OSI Pharmaceuticals
Glenmark Pharmaceuticals
Beacon Pharmaceuticals
Raichem Lifesciences
United Biotech
CJ Corporation
Vivimed Labs
Boryung Pharmaceutical
Taj Pharmaceuticals
Pharmascience
Natco Pharma
Intas Pharmaceuticals
RPG Life Sciences
Pharmascience
Schwarz Pharma
Dr. Reddy’s Laboratories
Glenmark Pharmaceuticals
Chugai Pharmaceutical
DKSH
Firma Chun Cheong
Kremers Urban Pharmaceuticals
Ortat
Zuellig Pharma
Major applications as follows:
Non-small Cell Lung Cancer
Pancreatic Cancer
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Roche
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Cipla
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Mylan
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Teva
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 OSI Pharmaceuticals
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Glenmark Pharmaceuticals
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Beacon Pharmaceuticals
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Raichem Lifesciences
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 United Biotech
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 CJ Corporation
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Vivimed Labs
3.12 Boryung Pharmaceutical
3.13 Taj Pharmaceuticals
3.14 Pharmascience
3.15 Natco Pharma
3.16 Intas Pharmaceuticals
3.17 RPG Life Sciences
3.18 Pharmascience
3.19 Schwarz Pharma
3.20 Dr. Reddy’s Laboratories
3.21 Glenmark Pharmaceuticals
3.22 Chugai Pharmaceutical
3.23 DKSH
3.24 Firma Chun Cheong
3.25 Kremers Urban Pharmaceuticals
3.26 Ortat
3.27 Zuellig Pharma
4 Major Application
4.1 Non-small Cell Lung Cancer
4.1.1 Overview
4.1.2 Non-small Cell Lung Cancer Market Size and Forecast
4.2 Pancreatic Cancer
4.2.1 Overview
4.2.2 Pancreatic Cancer Market Size and Forecast
5 Market Price
5.1 Overview
5.2 Price by SUK
6 Conclusion
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Roche
Tab Sales Revenue, Volume, Price, Cost and Margin of Cipla
Tab Sales Revenue, Volume, Price, Cost and Margin of Mylan
Tab Sales Revenue, Volume, Price, Cost and Margin of Teva
Tab Sales Revenue, Volume, Price, Cost and Margin of OSI Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Glenmark Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Beacon Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Raichem Lifesciences
Tab Sales Revenue, Volume, Price, Cost and Margin of United Biotech
Tab Sales Revenue, Volume, Price, Cost and Margin of CJ Corporation
Tab Sales Revenue, Volume, Price, Cost and Margin of Vivimed Labs
Tab Sales Revenue, Volume, Price, Cost and Margin of Boryung Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of Taj Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Pharmascience
Tab Sales Revenue, Volume, Price, Cost and Margin of Natco Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Intas Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of RPG Life Sciences
Tab Sales Revenue, Volume, Price, Cost and Margin of Pharmascience
Tab Sales Revenue, Volume, Price, Cost and Margin of Schwarz Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Dr. Reddy’s Laboratories
Tab Sales Revenue, Volume, Price, Cost and Margin of Glenmark Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Chugai Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of DKSH
Tab Sales Revenue, Volume, Price, Cost and Margin of Firma Chun Cheong
Tab Sales Revenue, Volume, Price, Cost and Margin of Kremers Urban Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Ortat
Tab Sales Revenue, Volume, Price, Cost and Margin of Zuellig Pharma
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
List Of Figures
Fig Global Erlotinib Hydrochloride Market Size and CAGR 2011-2017 (Value)
Fig Global Erlotinib Hydrochloride Market Size and CAGR 2011-2017 (Volume)
Fig Global Erlotinib Hydrochloride Market Forecast and CAGR 2018-2025 (Value)
Fig Global Erlotinib Hydrochloride Market Forecast and CAGR 2018-2025 (Volume)
Fig Non-small Cell Lung Cancer Market Size and CAGR 2011-2017 (Value)
Fig Non-small Cell Lung Cancer Market Size and CAGR 2011-2017 (Volume)
Fig Non-small Cell Lung Cancer Market Forecast and CAGR 2018-2025 (Value)
Fig Non-small Cell Lung Cancer Market Forecast and CAGR 2018-2025 (Volume)
Fig Pancreatic Cancer Market Size and CAGR 2011-2017 (Value)
Fig Pancreatic Cancer Market Size and CAGR 2011-2017 (Volume)
Fig Pancreatic Cancer Market Forecast and CAGR 2018-2025 (Value)
Fig Pancreatic Cancer Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...